כרומו קומוד תרסיס לאף ישראל - עברית - Ministry of Health

כרומו קומוד תרסיס לאף

kivema ltd - cromoglicic acid as sodium - ספריי לאף - cromoglicic acid as sodium 20 mg/ml - cromoglicic acid - cromoglicic acid - prophylactic treatment for allergic rhinitis, seasonal and perrenial.

קרומופטיק ישראל - עברית - Ministry of Health

קרומופטיק

vitamed pharmaceutical industries ltd - cromoglicic acid sodium - טיפות עיניים - cromoglicic acid sodium 2 %w/v - cromoglicic acid - cromoglicic acid - preventative treatment of all forms of allergic conjunctivitis.

קרונאז תרסיס לאף ישראל - עברית - Ministry of Health

קרונאז תרסיס לאף

vitamed ltd,binyamina - cromoglicic acid sodium 20 mg/ml - solution - cromoglicic acid - cronase is indicated for the prevention and treatment of seasonal and non seasonal allergic rhinitis.

כרומו קומוד טיפות עיניים ישראל - עברית - Ministry of Health

כרומו קומוד טיפות עיניים

kivema ltd - cromoglicic acid as sodium - טיפות עיניים - cromoglicic acid as sodium 20 mg/ml - cromoglicic acid

אופטיקרום טפות עיניים ישראל - עברית - Ministry of Health

אופטיקרום טפות עיניים

sanofi - aventis israel ltd - cromoglicic acid as sodium 2 %w/v - eye drops - cromoglicic acid - preventive treatment for all types of allergic conjunctivitis.

וילאט 1000 ישראל - עברית - Ministry of Health

וילאט 1000

dover medical & scientific equipment ltd, israel - factor viii (human); von willebrand factor - אבקה וממס להכנת תמיסה להזרקה - von willebrand factor 1000 iu/vial; factor viii (human) 1000 iu/vial - coagulation factor viii

וילאט 500 ישראל - עברית - Ministry of Health

וילאט 500

dover medical & scientific equipment ltd, israel - factor viii (human); von willebrand factor - אבקה וממס להכנת תמיסה להזרקה - von willebrand factor 500 iu/vial; factor viii (human) 500 iu/vial - coagulation factor viii

פלוטיפורם 505 ישראל - עברית - Ministry of Health

פלוטיפורם 505

rafa laboratories ltd - fluticasone propionate; formoterol fumarate dihydrate - תרחיף בלחץ לשאיפה - fluticasone propionate 0.05 mg/dose; formoterol fumarate dihydrate 0.005 mg/dose - fluticasone - fluticasone - the regular treatment of asthma where use of a combination product (an inhaled corticosteroid and a long -acting ?2 agonist) is appropriate:• for patients not adequately controlled with inhaled corticosteroids and ‘as required’ inhaled short -acting ?2 agonist.• for patients already adequately controlled on both an inhaled corticosteroid and a long-acting ?2 agonist.

פלוטיפורם 1255 ישראל - עברית - Ministry of Health

פלוטיפורם 1255

rafa laboratories ltd - fluticasone propionate; formoterol fumarate dihydrate - תרחיף בלחץ לשאיפה - fluticasone propionate 0.125 mg/dose; formoterol fumarate dihydrate 0.005 mg/dose - fluticasone - fluticasone - the regular treatment of asthma where use of a combination product (an inhaled corticosteroid and a long -acting ?2 agonist) is appropriate:• for patients not adequately controlled with inhaled corticosteroids and ‘as required’ inhaled short -acting ?2 agonist.• for patients already adequately controlled on both an inhaled corticosteroid and a long-acting ?2 agonist.

פלוטיפורם 25010 ישראל - עברית - Ministry of Health

פלוטיפורם 25010

rafa laboratories ltd - fluticasone propionate; formoterol fumarate dihydrate - תרחיף בלחץ לשאיפה - fluticasone propionate 0.25 mg/dose; formoterol fumarate dihydrate 0.01 mg/dose - fluticasone - fluticasone - the regular treatment of asthma where use of a combination product (an inhaled corticosteroid and a long -acting ?2 agonist) is appropriate:• for patients not adequately controlled with inhaled corticosteroids and ‘as required’ inhaled short -acting ?2 agonist.• for patients already adequately controlled on both an inhaled corticosteroid and a long-acting ?2 agonist.